Scarica l'app Stockscreener
148.85
1.08%
-1.63
Dopo l'orario di chiusura:
148.85
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MS Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$150.48
Aprire:
$148.56
Volume 24 ore:
5.33M
Relative Volume:
1.04
Capitalizzazione di mercato:
$237.61B
Reddito:
$109.29B
Utile/perdita netta:
$14.90B
Rapporto P/E:
16.86
EPS:
8.83
Flusso di cassa netto:
$20.03B
1 W Prestazione:
-0.08%
1M Prestazione:
+7.02%
6M Prestazione:
+11.82%
1 anno Prestazione:
+43.66%
Intervallo 1D:
$145.66
$149.07
Intervallo di 1 settimana:
$145.66
$150.75
Portata 52W:
$94.09
$150.75
Morgan Stanley Stock (MS) Company Profile
Nome
Morgan Stanley
Settore
Industria
Telefono
212-761-4000
Indirizzo
1585 BROADWAY, NEW YORK, NY
Confronta MS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MS
Morgan Stanley
|
148.85 | 240.22B | 109.29B | 14.90B | 20.03B | 8.83 |
|
GS
Goldman Sachs Group Inc
|
730.85 | 225.60B | 125.66B | 15.56B | 66.86B | 45.38 |
|
SCHW
Charles Schwab Corp
|
96.12 | 173.97B | 26.67B | 7.28B | 39.40B | 3.72 |
|
HOOD
Robinhood Markets Inc
|
100.84 | 92.45B | 3.59B | 1.79B | 876.00M | 0.96 |
|
LPLA
Lpl Financial Holdings Inc
|
362.83 | 29.16B | 14.13B | 1.12B | 45.45M | 14.62 |
Morgan Stanley Stock (MS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-09 | Aggiornamento | Keefe Bruyette | Mkt Perform → Outperform |
| 2024-11-26 | Downgrade | HSBC Securities | Buy → Hold |
| 2024-11-15 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-10-04 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-09-11 | Downgrade | Goldman | Buy → Neutral |
| 2024-08-02 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2024-07-17 | Downgrade | Oppenheimer | Outperform → Perform |
| 2024-01-17 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-01-17 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| 2024-01-09 | Downgrade | HSBC Securities | Buy → Hold |
| 2023-11-28 | Downgrade | Societe Generale | Buy → Hold |
| 2023-11-20 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| 2023-10-23 | Downgrade | Odeon | Buy → Hold |
| 2023-10-20 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2023-10-11 | Downgrade | UBS | Buy → Neutral |
| 2023-09-07 | Iniziato | HSBC Securities | Buy |
| 2023-07-12 | Aggiornamento | Odeon | Hold → Buy |
| 2023-01-18 | Downgrade | Citigroup | Buy → Neutral |
| 2023-01-10 | Aggiornamento | Odeon | Sell → Hold |
| 2023-01-04 | Downgrade | Wolfe Research | Outperform → Underperform |
| 2022-10-05 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-09-06 | Downgrade | Odeon | Hold → Sell |
| 2022-05-03 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2022-01-28 | Downgrade | Odeon | Buy → Hold |
| 2021-12-03 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-10-04 | Reiterato | Jefferies | Buy |
| 2021-09-29 | Downgrade | Oppenheimer | Outperform → Perform |
| 2021-09-28 | Downgrade | Berenberg | Buy → Hold |
| 2021-08-13 | Downgrade | Seaport Global Securities | Buy → Neutral |
| 2021-07-07 | Ripresa | Keefe Bruyette | Outperform |
| 2021-06-09 | Iniziato | Jefferies | Buy |
| 2021-04-21 | Aggiornamento | Berenberg | Hold → Buy |
| 2021-03-02 | Aggiornamento | Daiwa Securities | Neutral → Outperform |
| 2021-01-06 | Iniziato | Daiwa Securities | Neutral |
| 2021-01-04 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-11-10 | Downgrade | Citigroup | Buy → Neutral |
| 2020-10-13 | Ripresa | JP Morgan | Overweight |
| 2020-07-08 | Iniziato | Seaport Global Securities | Buy |
| 2020-06-24 | Aggiornamento | DA Davidson | Neutral → Buy |
| 2020-06-23 | Reiterato | UBS | Buy |
| 2020-05-21 | Aggiornamento | Odeon | Hold → Buy |
| 2020-04-14 | Aggiornamento | Societe Generale | Sell → Buy |
| 2020-03-13 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-03-04 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-02-21 | Downgrade | DA Davidson | Buy → Neutral |
| 2020-02-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-01-21 | Downgrade | Citigroup | Buy → Neutral |
| 2020-01-17 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-01-13 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2020-01-09 | Iniziato | DA Davidson | Buy |
| 2020-01-06 | Downgrade | Deutsche Bank | Buy → Hold |
| 2019-10-29 | Downgrade | Odeon | Buy → Hold |
| 2019-10-10 | Aggiornamento | Sandler O'Neill | Hold → Buy |
| 2019-07-12 | Aggiornamento | Citigroup | Neutral → Buy |
| 2019-04-18 | Downgrade | Citigroup | Buy → Neutral |
Mostra tutto
Morgan Stanley Borsa (MS) Ultime notizie
Bitcoin News Today: Institutional Bet: Morgan Stanley's Move Signals Crypto's Mainstream Makeover - AInvest
Kraft Heinz upgraded to Equal Weight from Underweight at Morgan Stanley - TipRanks
Morgan Stanley rates AIA as Equal-weight - MarketScreener
Morgan Stanley rates MQG as Equal-weight - MarketScreener
Morgan Stanley's 1.08% Drop Amid 44.83% Volume Surge to 790M Ranks 119th as Analysts Eye Strong Earnings Outlook and Premium Valuation - AInvest
Why Lam Research Stock Crumbled by 3% Today - The Motley Fool
Equinor downgraded to Underweight from Equal Weight at Morgan Stanley - TipRanks
Morgan Stanley (MS) Suffers a Larger Drop Than the General Market: Key Insights - sharewise.com
223,497 Shares in Morgan Stanley $MS Acquired by Kodai Capital Management LP - MarketBeat
Are Agency Mortgage-Backed Securities Making a Comeback? - Morgan Stanley
Morgan Stanley tips Fed for a dovish slam-dunk: three or more consecutive rate cuts coming - investingLive
Morgan Stanley Boosts Five Below (NASDAQ:FIVE) Price Target to $160.00 - MarketBeat
Teva to Present at Morgan Stanley Global Healthcare - GlobeNewswire
Healthcare Tech Leader Astrana Health Announces Triple Conference Schedule for September 2025 - Stock Titan
Definitive Healthcare to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference - GlobeNewswire
Biogen Participating in the Morgan Stanley 23rd Annual Global Healthcare Conference - Biogen
Tenaya Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference - GlobeNewswire
CDMO Leader Lifecore Biomedical Announces Triple Conference Schedule Including Morgan Stanley Healthcare - Stock Titan
Phibro Animal Health Corporation to Participate at Morgan Stanley Annual Global Healthcare Conference - Business Wire
Morgan Stanley Preferred Security stock chart pattern explained2025 Earnings Surprises & Daily Entry Point Trade Alerts - Newser
Morgan Stanley PMs taken off 4 funds with $3bn in combined assets - Citywire
Morgan Stanley Direct Lending: No Safety Margin (NYSE:MSDL) - Seeking Alpha
Using RSI to spot recovery in Morgan StanleyJuly 2025 Summary & Safe Capital Preservation Plans - Newser
Real time scanner hits for Morgan Stanley explainedInsider Selling & Precise Buy Zone Tips - Newser
Bank of Ireland price target raised to EUR 13.80 at Morgan Stanley - TipRanks
Fortive Shares Fall After Morgan Stanley Downgrade - MarketScreener
SailPoint Shares Rise After Morgan Stanley Upgrade - MarketScreener
Morgan Stanley Preferred Security Forms Bullish Flag — Upside Ahead getLinesFromResByArray error: size == 0 - thegnnews.com
Form 424B2 MORGAN STANLEY - StreetInsider
Will earnings trigger a reversal in Morgan Stanley Preferred SecurityJuly 2025 Patterns & Community Consensus Trade Alerts - Newser
Morgan Stanley: We Expect Fed Rate Cuts to Begin this Month but August NFP Key - eFXdata
Global Pet Healthcare Leader IDEXX Labs to Present at Morgan Stanley's 23rd Healthcare Conference - Stock Titan
Morgan Stanley wants Fed to lower its stress capital buffer - Banking Dive
Morgan Stanley ups Ionis target on ‘best-case scenario’ data - TipRanks
All You Need to Know About Morgan Stanley (MS) Rating Upgrade to Buy - ca.finance.yahoo.com
Exclusive: United Capital adds $1.1bn Morgan Stanley team in first deal post-Creative sale - Citywire
Morgan Stanley’s Mike Wilson: Healthcare could rebound amid near record low valuations - MSN
What candlestick patterns are forming on Morgan Stanley Preferred SecurityWeekly Loss Report & Reliable Intraday Trade Plans - Newser
Morgan Stanley’s Mike Wilson: Healthcare could rebound amid near record low valuations (XLV:NYSEARCA) - Seeking Alpha
These stocks are benefiting from China anti-involution tailwinds: Morgan Stanley - Investing.com
Fortinet receives downgrade as firewall refresh disappoints: Morgan Stanley - Seeking Alpha
Merck to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference - PharmiWeb.com
Beck Mack & Oliver LLC Raises Stock Position in Morgan Stanley $MS - MarketBeat
Morgan Stanley downgrades Lam Research, sees a challenging setup in 2026 - CNBC
Morgan Stanley Stock: Is MS Outperforming The Financial Sector? - Barchart.com
QXO rated Overweight in new coverage at Morgan Stanley; sees $50B growth opportunity (QXO:NYSE) - Seeking Alpha
Cyrus J. Lawrence LLC Lowers Stake in Morgan Stanley $MS - MarketBeat
SailPoint rises as Morgan Stanley upgrades, citing strength in identity market (SAIL:NASDAQ) - Seeking Alpha
Morgan Stanley’s Wilson Says US Stock Rally Has Further to Run - Bloomberg.com
Broadcom price target raised to $357 from $338 at Morgan Stanley - TipRanks
Leading MedTech Firm BioStem Technologies Announces Double-Header Investor Conference Schedule in NYC - Stock Titan
Morgan Stanley Azioni (MS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.93%
0.29%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):